Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chris Denton, MD
Professor of Experimental Rheumatology and Consultant Rheumatologist and Centre Head, Royal Free Hospital
Principal Investigator - Robert Spiera, MD
Professor of Clinical Medicine, Weill Cornell Medical College
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
74 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Adelaide Hospital
Adelaide, Australia
- Liverpool Hospital
Liverpool, Australia
- St Vincent'S Hospital
Melbourne, Australia
- Royal Prince Alfred Hospital
Sydney, Australia
- Sir Mortimer B. Davis Jewish General Hospital
Montreal, Canada
- the Arthritis Centre
Winnipeg, Canada
- Universitätsklinikum Heidelberg
Heidelberg, Baden-Wurttemberg, Germany
- Charité- Universitätsmedizin Berlin, Klinik Für Rheumatologie Und Klinische Immunologie, Abteilung -Neue Therapien & Studien-
Berlin, Germany
- University Hospital Cologne, Department of Dermatology and Venereology
Cologne, Germany
- Universitätsklinik Köln,klinik Und Poliklinik Für Dermatologie Und Venerologie
Cologne, Germany
- Department of Internal Medicine 3, University of Erlangen-Nuremberg
Erlangen, Germany
- University Medical Center Freiburg
Freiburg im Breisgau, Germany
- Kerckhoff-Klinik Gmbh, Zentrum Rheumatologie U. Klin. Immunologie, Studienambulanz
Nauheim, Germany
- University Hospital Ulm
Ulm, Germany
- Bnai Zion Medical Center
Haifa, Israel
- Rambam Health Corporation
Haifa, Israel
- Meir Medical Center - Internal Medicine E
Kfar Saba, Israel
- Sheba Medical Center
Ramat Gan, Israel
- Kyushu University Hospital
Fukuoka, Japan
- Kanazawa University Hospital
Kanazawa, Japan
- Gunma University Hospital
Maebashi, Japan
- Hokkaido University Hospital
Sapporo, Japan
- National University Corporation Tohoku University Tohoku University Hospital
Sendai, Japan
- Osaka University Hospital
Suita, Japan
- Nippon Medical School Hospital
Tokyo, Japan
- Yokohama City University Hospital
Yokohama, Japan
- Leiden University Medical Center
Leiden, South Holland, Netherlands
- Erasmus Medical Center
Rotterdam, Netherlands
- Haga Hospital
The Hague, Netherlands
- Samodzielny Publiczny Szpital Kliniczny Nr 1; Katedra I Klinika Dermatologii, Wenerologii I Dermatologii Dziecięcej Uniwersytetu Medycznego W Lublinie
Lublin, Poland
- Medyczne Centrum Hetmanska
Poznan, Poland
- Reum-Medica S.C
Wroclaw, Poland
- Asan Medical Center
Seoul, South Korea
- Hanyang University Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- the Catholic University of Korea, Seoul St. Mary'S Hospital
Seoul, South Korea
- Hospital Universitari de la Santa Creu I Sant Pau
Barcelona, Spain
- Hospital Universitario Doctor Peset
Valencia, Spain
- Cantonal Hospital St. Gallen
Sankt Gallen, Switzerland
- University Hospital Zurich
Zurich, Switzerland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Dec 2017
- Primary completion
- 27 May 2020
- Completion
- 21 Dec 2020
- Last update posted
- 29 Mar 2021
- Registered enrollment
- 365
- Registry id
- NCT03398837
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.